Table 3.

Individual results of second primary group

Patient no.	Location tumour 1	SUVmax tumour 1	Location tumour 2	SUVmax tumour 2	ΔSUVa	ΔSUV%b
1	Lung, RUL	4.50	Cecum	7.70	3.20	42
2	Lung, RLL	8.00	Lung, LLL	3.00	5.00	63
3	Lung, RML	20.7	Lung, RLL	5.00	15.7	76
4	Lung, RUL	10.3	Lung, LUL	8.40	1.90	18
5	Rectum	16.3	Lung, RUL	4.83	11.47	70
6	Colon	9.90	Lung, LLL	2.40	7.50	76
7	Lung, LUL	8.70	Lung, LLL	7.10	1.60	18
8	Soft palate	2.70	Lung, LUL	17.6	14.9	85
9	Lung, LUL	13.4	Lung, RML	6.70	6.70	50
10	Right oro/hypopharynx	18.0	Lung, LLL	5.20	12.8	71
11	Colon	19.4	Lung, LUL	5.70	13.7	71
12	Left oropharynx	23.4	Lung, RUL	7.60	15.8	68
13	Larynx	3.90	Lung, RLL	4.80	0.90	19
14	Lung, LUL	12.12	Lung, RLL	3.54	8.58	71
15	Colon	5.40	Lung, RUL	11.1	5.70	51
16	Left distal main bronchus	13.5	Lung, RUL	1.70	11.8	87
Mean ± SD					8.58 ± 5.24	58 ± 23

SUV _max maximum standardized uptake value, RUL right upper lobe, RLL right lower lobe, RML right middle lobe, LUL left upper lobe, LLL left lower lobe, SD standard deviation of the mean

^aThe absolute difference between the SUV_max of tumour 1 and SUV_max of tumour 2

^bThe relative difference between the SUV_max of tumour 1 and the SUV_max of tumour 2, expressed in percentages of the highest SUV_max